Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molina

Showing results (1221-1230 of 30,239) with videos related to

Pageof 3,024
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2001
In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS studyP Dargent-Molina, F Poitiers, G Bréart, et al.
Journal of Chemical Information and Computer Sciences|August 14, 2001
Can 3D structural parameters be predicted from 2D (topological) molecular descriptors?E Estrada, E Molina, I Perdomo-López
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Methyl 5-O-benzoyl-2,3-oxazole-D-ribofuranoside: a useful intermediate for the synthesis of conformationally restrained nucleosidesJ Molina, H L Maslen, C Simons
Critical Care Clinics|July 1, 1995
Theories and assumptions on energy expenditure. Determinations in the clinical settingP Molina, S Burzstein, N N Abumrad
European Journal of Pharmacology|April 24, 1995
The 5-HT2 receptor antagonist, pelanserin, inhibits alpha 1-adrenoceptor-mediated vasoconstriction in vitroR Villalobos-Molina, M Ibarra, E Hong
Cancer|August 1, 1983
Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's diseaseJ M Andrieu, M E Ochoa-Molina
Frontiers in Cellular and Infection Microbiology|November 3, 2018
A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for ToxoplasmosisCristian Rocha-Roa, Diego Molina, Néstor Cardona
CNS & Neurological Disorders Drug Targets|February 22, 2008
Tandem repeat peptide strategy for the design of neurotrophic factor mimeticsFrancisco Molina-Holgado, Patrick Doherty, Gareth Williams
Nature Protocols|March 8, 2008
Quantitative proteomics using stable isotope labeling with amino acids in cell cultureH C Harsha, Henrik Molina, Akhilesh Pandey
Polymers|May 16, 2020
Influence of the Degree of Cure in the Bulk Properties of Graphite Nanoplatelets Nanocomposites Printed via StereolithographyAlberto S de León, Sergio I Molina
Pageof 3,024

Showing results (1221-1230 of 30,239) with videos related to

Sort By:
Pageof 3,024
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 24, 2001
In elderly women weight is the best predictor of a very low bone mineral density: evidence from the EPIDOS studyP Dargent-Molina, F Poitiers, G Bréart, et al.
Journal of Chemical Information and Computer Sciences|August 14, 2001
Can 3D structural parameters be predicted from 2D (topological) molecular descriptors?E Estrada, E Molina, I Perdomo-López
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Methyl 5-O-benzoyl-2,3-oxazole-D-ribofuranoside: a useful intermediate for the synthesis of conformationally restrained nucleosidesJ Molina, H L Maslen, C Simons
Critical Care Clinics|July 1, 1995
Theories and assumptions on energy expenditure. Determinations in the clinical settingP Molina, S Burzstein, N N Abumrad
European Journal of Pharmacology|April 24, 1995
The 5-HT2 receptor antagonist, pelanserin, inhibits alpha 1-adrenoceptor-mediated vasoconstriction in vitroR Villalobos-Molina, M Ibarra, E Hong
Cancer|August 1, 1983
Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's diseaseJ M Andrieu, M E Ochoa-Molina
Frontiers in Cellular and Infection Microbiology|November 3, 2018
A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for ToxoplasmosisCristian Rocha-Roa, Diego Molina, Néstor Cardona
CNS & Neurological Disorders Drug Targets|February 22, 2008
Tandem repeat peptide strategy for the design of neurotrophic factor mimeticsFrancisco Molina-Holgado, Patrick Doherty, Gareth Williams
Nature Protocols|March 8, 2008
Quantitative proteomics using stable isotope labeling with amino acids in cell cultureH C Harsha, Henrik Molina, Akhilesh Pandey
Polymers|May 16, 2020
Influence of the Degree of Cure in the Bulk Properties of Graphite Nanoplatelets Nanocomposites Printed via StereolithographyAlberto S de León, Sergio I Molina
Pageof 3,024